Recruiting NA Bradykinesia

New treatment option for Bradykinesia

Official title prTMS as an Intervention for Bradykinesia in Parkinson's Disease

ClinicalTrials.gov ID: NCT07397377

What this study is testing

What it's testing
This study investigates the use of patterned repetitive transcranial magnetic stimulation (prTMS) as an intervention for bradykinesia in Parkinson's Disease (PD). More specifically, the study aims to determine whether prTMS over the supplementary motor area (SMA) can reduce severity of bradykinesia in PD patients.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 80

You may be able to join if

  • Above 18 years of age. Clinically established or probable Parkinson's Disease (PD), according to the Movement Disorder Society.
  • Clinical Diagnostic Criteria for PD. Stable antiparkinsonian medicine for at least four weeks. Signed informed consent.

You likely can't join if

  • Psychiatric disorders. Current use of antipsychotic medication, Donepezil, or GABAergic agents (e.g., pregabalin, gabapentin).
  • Frequent benzodiazepine or opioid use defined as more than once per week on a regular basis.
  • History of neurological disease other than PD. Past or present mental illness. History of epilepsy/conditions associated with increased risk of...
  • Close relatives suffering from epilepsy/conditions associated with increased risk of seizures.
  • Contraindications for magnetic resonance imaging (MRI) Contraindications for TMS Female participants of childbearing age must not be pregnant and...
  • Refuse to be informed about new health-related information and accidental health-related findings that might appear through participation in the...

The study team makes the final eligibility decision.

Where it's taking place

  • Hvidovre, Denmark

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Hvidovre, Denmark. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.